Vimarsana
Biggest News Aggregation in the World

Andera Midcap News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andera Midcap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andera Midcap Today - Breaking & Trending Today

Nouscom Raises €67.5 million ($72 million) in - Vimarsana News

Nouscom Raises €67.5 million ($72 million) in

New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its...

Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round - Vimarsana News

Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round

New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of...

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic - Vimarsana News

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting

EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases - Vimarsana News

EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023

Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline - Vimarsana News

Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline

New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million Funds will be used to advance clinical